SCHEMBL24194430

SCHEMBL24194430

CCCCOc1cccc2c1C(=O)C=CC2=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLM Q9NP87 2/20 0.60
▸ POLK Q9UBT6 2/20 0.60
▸ POLL Q9UGP5 2/20 0.60
▸ POLH Q9Y253 2/20 0.60
▸ TOP1 P11387 3/20 0.60
▸ CDC25B P30305 2/20 0.49
▸ CDC25A P30304 1/20 0.49
▸ CDC25C P30307 1/20 0.49
▸ ELANE P08246 2/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2C9 P11712 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ CYP19A1 P11511 1/20 0.46
▸ TDP1 Q9NUW8 2/20 0.43
▸ TP53 P04637 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ KMT2A Q03164 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30574283 0.85 TOP1 (0.66) POLMPOLKPOLLPOLHTOP1
SCHEMBL24194098 0.85 TOP1 (0.66) POLMPOLKPOLLPOLHTOP1
SCHEMBL16076555 0.81 KCNA3 (0.62) ELANECYP1A2CYP2C9CYP2C19CYP19A1
SCHEMBL9017760 0.80 ELANE (0.67) ELANECYP1A2CYP2C9CYP2C19CYP19A1
SCHEMBL21076346 0.79 ALDH1A1 (0.64) POLMPOLKPOLLPOLHCDC25B
SCHEMBL28986871 0.77 KCNA3 (0.70) ELANECYP1A2CYP2C9CYP2C19CYP19A1
SCHEMBL21543711 0.77 CYP1A2 (0.49) ELANECYP1A2CYP2C9CYP2C19CYP19A1
SCHEMBL9711411 0.77 TOP1 (0.51) POLMPOLKPOLLPOLHTOP1
SCHEMBL3414850 0.75 TOP1 (1.00) POLMPOLKPOLLPOLHTOP1
SCHEMBL30003440 0.75 TOP1 (1.00) POLMPOLKPOLLPOLHTOP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113368087-A Juglone derivatives and application thereof in preparation of drugs for treating brain tumors through chemotherapy 复旦大学附属华山医院 2021-09-10 — — CN claimed
US-20220011488-A1 COMPOUND, POLYMERIZABLE COMPOSITION, CURED PRODUCT, OPTICAL FILM, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2022-01-13 — — US disclosed
CN-113368087-A Juglone derivatives and application thereof in preparation of drugs for treating brain tumors through chemotherapy 复旦大学附属华山医院 2021-09-10 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220011488-A1 COMPOUND, POLYMERIZABLE COMPOSITION, CURED PRODUCT, OPTICAL FILM, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE PDAP1, PHOSPHO1, DAD1 POLM 2824/4885POLK 3298/4885POLL 2248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback